Skip to main content
. Author manuscript; available in PMC: 2014 Jun 11.
Published in final edited form as: Biol Blood Marrow Transplant. 2012 Dec 7;19(3):474–480. doi: 10.1016/j.bbmt.2012.12.001

Table 3B.

Transplant Outcomes Dose Level 5 vs. Others

Dose Level 5 (N=58) Other dose levels (N=22) P Value
Graft Failure 2 2 NS
Time to Neutrophil Engraftment,(days) 13 13 NS
Time to platelet Engraftment, (days) 15 18 NS
Grade 2–4 aGVHD 17 (29.3%) 9 (42%) NS
Chronic GVHD 19 (32.8%) 4 (13.6%) 0.087
Progression, n 25 (43%) 15 (68%) 0.045
Dead, n 43 (74%) 20 (91%) 0.1